期刊文献+

糖尿病足感染的病原菌分布与耐药性分析 被引量:15

Bacterial distribution and resistance in diabetic foot infection
原文传递
导出
摘要 目的了解糖尿病足感染细菌的分布及耐药状况。方法收集2010年至2017年门诊和住院患者的糖尿病足感染标本,常规方法进行细菌培养和鉴定,按纸片法、微量稀释法或E-test法测定细菌药物敏感性。结果共分离出非重复细菌304株,排在前4位的依次是金黄色葡萄球菌、铜绿假单胞菌、无乳链球菌和奇异变形杆菌,分别占29.3%,8.6%,5.9%,5.6%。未检出万古霉素耐药的革兰氏阳性细菌,未检出碳青霉烯类耐药的革兰氏阴性细菌。结论糖尿病足感染的主要致病菌仍以金黄色葡萄球菌为主。 Objective To investigate the bacterial distribution and resistance to antibiotic in diabetic foot infection (DFI). Methods All the stains of outpatients and inpatients were isolated from infectious tissue in 2010- 2017. The stains were cultured and identified by conventional method, and their susceptibility were tested by disk diffusion, microbroth dilution or E - test according to Clinical and Laboratory Standard Institute (CLSI, 2015) manual Results A total of 304 strains were collected. The four main species were Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus agalaetiae, and Proteus mirabilis, accounting for 29.3% , 8.6% , 5.9% and 5.6% respectively. There was no resistance to vancomycin for gram -positive bacteria, and no resistance to carbapenem for gram - nagetive bacteria. Conclusion Staphylococcus aureus was predominant organism in DFI.
作者 温冰 何睿 齐心 李湘燕 孙立颖 姜珊 甘良雨 郭晓蕙 WEN Bing1a, HE Rui1a, QI Xin1a, LI Xiang -yan1b, SUN Li -ying1b, JIANG Shan1a, GAN Liang - yu1a, GUO Xiao - hui1d(1. a Department of Plastic and Bum Surgery; b. Department of Anti - infection; a Department of Clinical Laboratories; d. Department of Endocrinology, Peking University First Hospital, Beijing 100034, Chin)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第6期670-673,共4页 The Chinese Journal of Clinical Pharmacology
基金 北京市科技计划课题基金资助项目(D141107005314003) 北京大学第一医院青年临床研究专项基金资助项目(2017CR13)
关键词 糖尿病足感染 细菌分布 细菌耐药 diabetic foot infection bacterial distribution drug resistance
  • 相关文献

参考文献3

二级参考文献31

  • 1邓家德,李红玉,陈惠玲,叶惠芬,杨银梅,熊剑辉.糖尿病足溃疡处常见病原菌分布与耐药性分析[J].中华医院感染学杂志,2005,15(8):955-957. 被引量:73
  • 2冯霞,林红燕,杨俊何,魏衍超,张春梅.铜绿假单孢菌耐药性与广谱抗菌药物消耗量相关性研究[J].中国医院用药评价与分析,2006,6(3):159-162. 被引量:26
  • 3Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035 for the IDF Diabetes Atlas[ J]. Diabetes Res Clin Pract, 2013, 103: 137-149.
  • 4Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes [ J ]. JAMA,2005,293:217-228.
  • 5Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study[ J]. Diabetologia,2008, 51:1826-1834.
  • 6Wild S,Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 [J]. Diab Care ,2004,27 : 1047-1053.
  • 7Fard AS,Esmaelzadeh M,Larijani B. Assessment and treatment of diabetic foot ulcer[ J]. Int J Clin Pract,2007,61:1931-1938.
  • 8Lavery LA,Armstrong DG, Wunderlich RP, et al. Risk factors for foot infection in individuals with diabetes [ J ]. Diabetes Care, 2006,29 : 1288-1293.
  • 9Wagner FW. The dysvascular foot: A system for diagnosis and treatment[ J]. Foot Ankle, 1981,2:64-122.
  • 10朱建国,周贵民.临床微生物的常规鉴定[M]//页应妩,王毓三,申子瑜.全国临床检验操作规程,3版.南京:东南大学出版社,2006:754-889.

共引文献90

同被引文献83

引证文献15

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部